April 25-27, 2014 - High School Students
The Dr. Nelson Ying Science Competition encourages students to help humanity through scientific research. High-schoolers submit research papers to be reviewed by a distinguished panel of judges to select five finalists. Finalists are invited to participate in a three-day, expenses-paid event, concluded by an awards luncheon to announce the “Ying Prize” of $5,000 to the student, $1,000 to their teacher and $1,000 to their principal!
Every year for over a decade, Dr. Nelson Ying hosts this competition in collaboration with the Orlando Science Center. Ying is a philanthropist, scientist and entrepreneur. He wants to inspire tomorrow's science leaders today, so he has worked with the Science Center to create this elite competition. This competition not only honors innovative student science research but also exemplary teens.
Dr. Ying Competition 2014 Information
Papers Due: 5:00 p.m. March 21, 2014
Finalists Notified: April 8, 2014
Competition Weekend: April 25-27, 2014
New this year! Papers will be submitted through our DROPitTOme Account - simply click on the link and type in “ying” for the password. More detailed information on how to submit your papers is located here: DROPitTOme Instructions.
18 April 2014
Posted in Dr. Ying Competition
Catherine Li is a Junior at Lake Highland Preparatory School in Orange County where she is involved in the ASPIRE Research Program, varsity volleyball, varsity track, Mu Alpha Theta and serves as president of both the Student Government Association and National Honor Society. She is inspired by scientific research and its potential to improve human conditions around the globe.
Over the past few years, Catherine has had the amazing opportunity of researching at the CREOL College of Optics and Photonics and the Burnett School of Biomedical Sciences at the University of Central Florida. With strong interest in biomedical engineering, Catherine’s project focuses on the development of a new method to synthesizing nanoparticles especially designed for drug delivery applications, with an ultimate goal of cancer treatment.